Next-Generation Sequencing (NGS) In Precision Medicine Market Insights On Growth Drivers, Trends, And Opportunities
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Next-Generation Sequencing (NGS) In Precision Medicine Market Expected To Change From 2026 To 2030? _x000D_
The next-generation sequencing (NGS) in precision medicine market has experienced rapid growth in recent years. It is anticipated to expand from $6.42 billion in 2025 to $7.52 billion in 2026, at a compound annual growth rate (CAGR) of 17.2%. The historical increase in the market size can be attributed to the advancement of high-throughput sequencers, increasing understanding of personalized medicine, the progression of genomic research, the proliferation of bioinformatics software, and the integration of precision medicine into clinical trials._x000D_
_x000D_
The next-generation sequencing (ngs) in precision medicine market is anticipated to experience substantial expansion in the coming years. By 2030, this market is projected to reach $14.05 billion, demonstrating a compound annual growth rate (CAGR) of 16.9%. This projected growth during the forecast period is attributable to several factors, including ongoing technological progress in sequencing instruments, the incorporation of AI into genomics, the proliferation of cloud-based sequencing services, a rise in collaborations between pharmaceutical and biotechnology firms, and the spread of precision medicine into developing areas. Key trends anticipated within this period encompass AI-driven genomic analysis, the adoption of cloud-based sequencing solutions, the broader application of personalized medicine, increased automation in sequencing processes, and real-time interpretation of genomic data._x000D_
_x000D_
#Access Your Free Sample Report For In-Depth Market Analysis:#_x000D_
_x000D_
What Leading Drivers Are Supporting The Next-Generation Sequencing (NGS) In Precision Medicine Market Expansion?_x000D_
The increasing occurrence of genetic disorders is anticipated to propel the expansion of the next-generation sequencing (NGS) in precision medicine market in the coming years. Genetic disorders are defined as illnesses or conditions resulting from irregularities in an individual’s DNA, which can be inherited or arise due to mutations. The frequency of genetic disorders is rising as advancements in diagnostic technologies, such as genetic screening and next-generation sequencing, allow medical professionals to identify cases that previously went undetected, leading to a higher reported prevalence. Next-generation sequencing in precision medicine assists in detecting genetic mutations, facilitating accurate diagnosis, personalized treatments, and early intervention for genetic disorders. For instance, in May 2024, according to the National Health Service, a UK-based government department, approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. Therefore, the growing incidence of genetic disorders is driving the growth of the next-generation sequencing (NGS) in precision medicine market._x000D_
_x000D_
What Segment Categories Shape The Next-Generation Sequencing (NGS) In Precision Medicine Market Segment Landscape?_x000D_
The next-generation sequencing (ngs) in precision medicine market covered in this report is segmented – _x000D_
_x000D_
1) By Product And Service: Sequencing Instruments, Consumables And Reagents, Library Preparation Kits, Bioinformatics Software, Next-Generation Sequencing (NGS) Services_x000D_
2) By Technology: Whole Genome Sequencing (WGS), Whole Exome Sequencing (Wes), Targeted Sequencing, Ribonucleic Acid (RNA) Sequencing, Single-Cell Sequencing_x000D_
3) By Application: Oncology, Infectious Disease, Rare And Inherited Disorders, Prenatal And Reproductive Health, Pharmacogenomics_x000D_
4) By End Use: Hospitals And Clinics, Academic And Research Institutions, Biopharmaceutical Companies, Diagnostic Laboratories, Contract Research Organizations (CROs)_x000D_
_x000D_
Subsegments:_x000D_
1) By Sequencing Instruments: Benchtop Sequencers, High Throughput Sequencers_x000D_
2) By Consumables And Reagents: Sequencing Reagents, Sequencing Chips, Flow Cells, Sample Preparation Reagents_x000D_
3) By Library Preparation Kits: Deoxyribonucleic Acid (DNA) Library Preparation Kits, Ribonucleic Acid (RNA) Library Preparation Kits, Whole Genome Amplification Kits, Target Enrichment Kits_x000D_
4) By Bioinformatics Software: Data Analysis Software, Data Management Software, Sequence Alignment Software, Variant Calling Software_x000D_
5) By Next-Generation Sequencing Services: Whole Genome Sequencing Services, Whole Exome Sequencing Services, Targeted Sequencing Services, Ribonucleic Acid (RNA) Sequencing Services, Epigenomic Sequencing Services_x000D_
_x000D_
What Emerging Trends Are Seen In The Next-Generation Sequencing (NGS) In Precision Medicine Market?_x000D_
Leading companies in the next-generation sequencing (NGS) in precision medicine market are concentrating on developing innovative solutions, such as multimodal DNA and RNA library kits, to improve the effectiveness and accuracy of genomic analyses. A multimodal DNA and RNA library kit serves as a laboratory tool that enables the concurrent preparation of sequencing libraries from both DNA and RNA within a single process, thereby allowing for a comprehensive analysis of a sample’s genome and transcriptome. As an example, in May 2024, Qiagen N.V., a Germany-based provider of sample and assay technologies for molecular diagnostics, introduced its QIAseq Multimodal DNA and RNA Library Kit. This particular next-generation sequencing solution facilitates multiomic studies and advances precision medicine by enabling streamlined DNA and RNA library preparation from a single sample. This kit supports whole genome and whole transcriptome sequencing, as well as downstream target enrichment, simplifying multiomic studies by integrating optimized chemistry for DNA and RNA simultaneously. It significantly reduces the necessity for large sample quantities and labor-intensive procedures commonly found in traditional separate DNA and RNA workflows. By boosting efficiency in multiomic research, this kit contributes to the progress of precision medicine through enhanced biomarker discovery and a deeper understanding of diseases, particularly in cancer research._x000D_
_x000D_
Who Are The Companies Operating Across The Next-Generation Sequencing (NGS) In Precision Medicine Market Value Chain?_x000D_
Major companies operating in the next-generation sequencing (ngs) in precision medicine market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V., Natera Inc., Tempus Labs Inc., 10x Genomics Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Caris Life Sciences Inc., Fulgent Genetics Inc., Twist Bioscience Corporation, Pacific Biosciences of California Inc., Macrogen Inc., Ultima Genomics Inc., Personalis Inc., Element Biosciences Inc., Genomenon Inc., Strand Life Sciences Pvt. Ltd., Singular Genomics Systems Inc. _x000D_
_x000D_
#Get The Full Next-Generation Sequencing (NGS) In Precision Medicine Market Report:#_x000D_
_x000D_
Where Is The Next-Generation Sequencing (NGS) In Precision Medicine Market Most Concentrated Geographically?_x000D_
North America was the largest region in the next-generation sequencing (NGS) in precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing (ngs) in precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request A Customized Next-Generation Sequencing (NGS) In Precision Medicine Market Report For Competitive Insights:#_x000D_
_x000D_
#Browse Through More Reports Similar to the Global Next-Generation Sequencing (NGS) In Precision Medicine Market 2026, By The Business Research Company#_x000D_
_x000D_
Ngs Based Rna Sequencing Market Report 2026_x000D_
_x000D_
Next Generation Sequencing Market 2026_x000D_
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market_x000D_
_x000D_
Clinical Oncology Next Generation Sequencing Market Report 2026_x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
